Status: current, Defined. Date: 31-Oct 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4649461012 | Tivozanib (as tivozanib hydrochloride) 1.34 mg oral capsule | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 4649462017 | Product containing precisely tivozanib (as tivozanib hydrochloride) 1.34 milligram/1 each conventional release oral capsule (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tivozanib (as tivozanib hydrochloride) 1.34 mg oral capsule | Is a | Tivozanib only product in oral dose form | true | Inferred relationship | Some | ||
| Tivozanib (as tivozanib hydrochloride) 1.34 mg oral capsule | Has manufactured dose form | Conventional release oral capsule | true | Inferred relationship | Some | ||
| Tivozanib (as tivozanib hydrochloride) 1.34 mg oral capsule | Has unit of presentation | Capsule | true | Inferred relationship | Some | ||
| Tivozanib (as tivozanib hydrochloride) 1.34 mg oral capsule | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Tivozanib (as tivozanib hydrochloride) 1.34 mg oral capsule | Has precise active ingredient | Tivozanib hydrochloride | true | Inferred relationship | Some | 1 | |
| Tivozanib (as tivozanib hydrochloride) 1.34 mg oral capsule | Has BoSS | Tivozanib | true | Inferred relationship | Some | 1 | |
| Tivozanib (as tivozanib hydrochloride) 1.34 mg oral capsule | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Tivozanib (as tivozanib hydrochloride) 1.34 mg oral capsule | Has presentation strength denominator unit | Capsule | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR